MK-0431/ONO-5435
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for MK-0431/ONO-5435, covering 2012-06-13 to 2019-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) [Phase 2]